SE454646B - Erektions- och fertilitetsbefremjande medel fran cowper's- och/eller bartholini's kortlar fran deggdjur inbegripet menniskan samt sett for framstellning derav - Google Patents
Erektions- och fertilitetsbefremjande medel fran cowper's- och/eller bartholini's kortlar fran deggdjur inbegripet menniskan samt sett for framstellning deravInfo
- Publication number
- SE454646B SE454646B SE8400752A SE8400752A SE454646B SE 454646 B SE454646 B SE 454646B SE 8400752 A SE8400752 A SE 8400752A SE 8400752 A SE8400752 A SE 8400752A SE 454646 B SE454646 B SE 454646B
- Authority
- SE
- Sweden
- Prior art keywords
- glands
- cowper
- factor
- bartholini
- fractions
- Prior art date
Links
- 230000035558 fertility Effects 0.000 title claims abstract description 6
- 238000004519 manufacturing process Methods 0.000 title abstract description 3
- 241000282414 Homo sapiens Species 0.000 title description 9
- 150000002632 lipids Chemical class 0.000 claims abstract description 22
- 210000001072 colon Anatomy 0.000 claims abstract description 20
- 241000699694 Gerbillinae Species 0.000 claims abstract description 18
- 239000000203 mixture Substances 0.000 claims abstract description 16
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 12
- 239000002871 fertility agent Substances 0.000 claims abstract description 4
- 210000004907 gland Anatomy 0.000 claims description 42
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 24
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 16
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 13
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- 238000004587 chromatography analysis Methods 0.000 claims description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- 239000000741 silica gel Substances 0.000 claims description 5
- 229910002027 silica gel Inorganic materials 0.000 claims description 5
- 230000002378 acidificating effect Effects 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 239000003480 eluent Substances 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 claims description 2
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 claims description 2
- 238000005194 fractionation Methods 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 3
- 208000010228 Erectile Dysfunction Diseases 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 230000001856 erectile effect Effects 0.000 claims 1
- 201000001881 impotence Diseases 0.000 claims 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 claims 1
- 210000002533 bulbourethral gland Anatomy 0.000 abstract description 14
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 210000002947 bartholin's gland Anatomy 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 16
- 210000000582 semen Anatomy 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 150000003180 prostaglandins Chemical class 0.000 description 13
- 210000001367 artery Anatomy 0.000 description 11
- 239000000284 extract Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 230000008602 contraction Effects 0.000 description 10
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 10
- 210000005226 corpus cavernosum Anatomy 0.000 description 9
- 235000014103 egg white Nutrition 0.000 description 9
- 230000004071 biological effect Effects 0.000 description 8
- 210000000969 egg white Anatomy 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 210000003899 penis Anatomy 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 210000002460 smooth muscle Anatomy 0.000 description 8
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 7
- 102000002322 Egg Proteins Human genes 0.000 description 7
- 108010000912 Egg Proteins Proteins 0.000 description 7
- 244000309464 bull Species 0.000 description 7
- 210000003708 urethra Anatomy 0.000 description 7
- 238000004166 bioassay Methods 0.000 description 6
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 6
- 229960002986 dinoprostone Drugs 0.000 description 6
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 238000004440 column chromatography Methods 0.000 description 5
- 230000004899 motility Effects 0.000 description 5
- 230000002997 prostaglandinlike Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 101001002508 Homo sapiens Immunoglobulin-binding protein 1 Proteins 0.000 description 4
- 102100021042 Immunoglobulin-binding protein 1 Human genes 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- 239000004809 Teflon Substances 0.000 description 4
- 229920006362 Teflon® Polymers 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 235000013601 eggs Nutrition 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 4
- 230000003389 potentiating effect Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000003387 muscular Effects 0.000 description 3
- 230000019100 sperm motility Effects 0.000 description 3
- 210000001215 vagina Anatomy 0.000 description 3
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 2
- 244000003363 Allium ursinum Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- AUALQMFGWLZREY-UHFFFAOYSA-N acetonitrile;methanol Chemical compound OC.CC#N AUALQMFGWLZREY-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 210000000991 chicken egg Anatomy 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 230000004720 fertilization Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229960001789 papaverine Drugs 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000007903 penetration ability Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 238000003307 slaughter Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- DZUXGQBLFALXCR-UHFFFAOYSA-N (+)-(9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprost-13-en-1-oic acid Natural products CCCCCC(O)C=CC1C(O)CC(O)C1CCCCCCC(O)=O DZUXGQBLFALXCR-UHFFFAOYSA-N 0.000 description 1
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 description 1
- VFYFMNCKPJDAPV-UHFFFAOYSA-N 2,2'-(5-oxo-1,3-dioxolan-4,4-diyl)diessigs Chemical compound C1N(C2)CN3CN1CN2C3.OC(=O)CC1(CC(O)=O)OCOC1=O VFYFMNCKPJDAPV-UHFFFAOYSA-N 0.000 description 1
- 101100310593 Candida albicans (strain SC5314 / ATCC MYA-2876) SOD4 gene Proteins 0.000 description 1
- 101000862089 Clarkia lewisii Glucose-6-phosphate isomerase, cytosolic 1A Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 101100412102 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) rec2 gene Proteins 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- QZVCTJOXCFMACW-UHFFFAOYSA-N Phenoxybenzamine Chemical compound C=1C=CC=CC=1CN(CCCl)C(C)COC1=CC=CC=C1 QZVCTJOXCFMACW-UHFFFAOYSA-N 0.000 description 1
- MYHXHCUNDDAEOZ-UHFFFAOYSA-N Prostaglandin A&2% Natural products CCCCCC(O)C=CC1C=CC(=O)C1CC=CCCCC(O)=O MYHXHCUNDDAEOZ-UHFFFAOYSA-N 0.000 description 1
- 101100190148 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PGA2 gene Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- OTEVZAMXUZPZRG-UHFFFAOYSA-N acetic acid ethanol ethyl acetate 2,2,4-trimethylpentane hydrate Chemical compound O.C(C)(=O)O.C(C)O.C(C)(C)CC(C)(C)C.C(C)OC(C)=O OTEVZAMXUZPZRG-UHFFFAOYSA-N 0.000 description 1
- NAYRZLVSOLIQSH-UHFFFAOYSA-N acetonitrile;methanol;phosphoric acid Chemical compound OC.CC#N.OP(O)(O)=O NAYRZLVSOLIQSH-UHFFFAOYSA-N 0.000 description 1
- 229960000711 alprostadil Drugs 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000011953 bioanalysis Methods 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- YUWSEANKNXEZCL-UHFFFAOYSA-N chloroform ethanol formic acid propan-2-ol Chemical compound C(=O)O.C(C)O.C(C)(C)O.C(Cl)(Cl)Cl YUWSEANKNXEZCL-UHFFFAOYSA-N 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 230000000687 effect on sperms Effects 0.000 description 1
- 210000005225 erectile tissue Anatomy 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 238000009802 hysterectomy Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229940039412 ketalar Drugs 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 210000002346 musculoskeletal system Anatomy 0.000 description 1
- 210000000754 myometrium Anatomy 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960003418 phenoxybenzamine Drugs 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- IWZKICVEHNUQTL-UHFFFAOYSA-M potassium hydrogen phthalate Chemical compound [K+].OC(=O)C1=CC=CC=C1C([O-])=O IWZKICVEHNUQTL-UHFFFAOYSA-M 0.000 description 1
- MYHXHCUNDDAEOZ-FOSBLDSVSA-N prostaglandin A2 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1C=CC(=O)[C@@H]1C\C=C/CCCC(O)=O MYHXHCUNDDAEOZ-FOSBLDSVSA-N 0.000 description 1
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 description 1
- KAQKFAOMNZTLHT-OZUDYXHBSA-N prostaglandin I2 Chemical compound O1\C(=C/CCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-OZUDYXHBSA-N 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 210000004739 secretory vesicle Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 210000001585 trabecular meshwork Anatomy 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Table Devices Or Equipment (AREA)
- Conveying And Assembling Of Building Elements In Situ (AREA)
- Television Signal Processing For Recording (AREA)
- Detergent Compositions (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Pipeline Systems (AREA)
- Medicinal Preparation (AREA)
- Lining And Supports For Tunnels (AREA)
- Load-Engaging Elements For Cranes (AREA)
- Tents Or Canopies (AREA)
- Supports For Plants (AREA)
- Moulds, Cores, Or Mandrels (AREA)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8400752A SE454646B (sv) | 1984-02-13 | 1984-02-13 | Erektions- och fertilitetsbefremjande medel fran cowper's- och/eller bartholini's kortlar fran deggdjur inbegripet menniskan samt sett for framstellning derav |
| IL74183A IL74183A (en) | 1984-02-13 | 1985-01-29 | Erection and fertility promoting agent and method for producing the same |
| AU39366/85A AU586157B2 (en) | 1984-02-13 | 1985-02-12 | Gland extracxtion process |
| JP85500792A JPS61501394A (ja) | 1984-02-13 | 1985-02-12 | 勃起および受精能力増進剤、その製造方法、ならびにその勃起および受精能力増進組成物における使用 |
| DE8585901111T DE3570039D1 (en) | 1984-02-13 | 1985-02-12 | An erection and fertility promoting agent, a method for producing the same, and the use thereof in the production of erection and fertility promoting compositions |
| PCT/SE1985/000070 WO1985003441A1 (en) | 1984-02-13 | 1985-02-12 | An erection and fertility promoting agent, a method for producing the same, and the use thereof in the production of erection and fertility promoting compositions |
| CA000474058A CA1240922A (en) | 1984-02-13 | 1985-02-12 | Erection and fertility promoting agent, a method for producing the same, and the use thereof in the production of erection and fertility promoting compositions |
| AT85901111T ATE42897T1 (de) | 1984-02-13 | 1985-02-12 | Ein erektions- und fruchtbarkeitsfoerderndes mittel, verfahren zu dessen herstellung und dessen verwendung bei der erzeugung von erektions- und fruchtbarkeitsfoerdernden zusammensetzungen. |
| ES540308A ES8607729A1 (es) | 1984-02-13 | 1985-02-12 | Un procedimiento de producir un agente promotor de la erec- cion y de la fertilidad |
| EP85901111A EP0172873B1 (de) | 1984-02-13 | 1985-02-12 | Ein erektions- und fruchtbarkeitsförderndes mittel, verfahren zu dessen herstellung und dessen verwendung bei der erzeugung von erektions- und fruchtbarkeitsfördernden zusammensetzungen |
| DK432085A DK160536C (da) | 1984-02-13 | 1985-09-24 | Erektions- og frugtbarhedsfremmende middel og fremgangsmaade til dets fremstilling |
| FI853664A FI80593C (fi) | 1984-02-13 | 1985-09-24 | Foerfarande foer framstaellning av ett preparat foer begraemjande av erektion och fertilitet. |
| NO85854049A NO165944C (no) | 1984-02-13 | 1985-10-11 | Fremgangsmaate ved fremstilling av ereksjons- og fruktbarhetsfremmende middel. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8400752A SE454646B (sv) | 1984-02-13 | 1984-02-13 | Erektions- och fertilitetsbefremjande medel fran cowper's- och/eller bartholini's kortlar fran deggdjur inbegripet menniskan samt sett for framstellning derav |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8400752D0 SE8400752D0 (sv) | 1984-02-13 |
| SE8400752L SE8400752L (sv) | 1985-08-14 |
| SE454646B true SE454646B (sv) | 1988-05-24 |
Family
ID=20354713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8400752A SE454646B (sv) | 1984-02-13 | 1984-02-13 | Erektions- och fertilitetsbefremjande medel fran cowper's- och/eller bartholini's kortlar fran deggdjur inbegripet menniskan samt sett for framstellning derav |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0172873B1 (de) |
| JP (1) | JPS61501394A (de) |
| AT (1) | ATE42897T1 (de) |
| AU (1) | AU586157B2 (de) |
| CA (1) | CA1240922A (de) |
| DE (1) | DE3570039D1 (de) |
| DK (1) | DK160536C (de) |
| ES (1) | ES8607729A1 (de) |
| FI (1) | FI80593C (de) |
| IL (1) | IL74183A (de) |
| NO (1) | NO165944C (de) |
| SE (1) | SE454646B (de) |
| WO (1) | WO1985003441A1 (de) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE670599C (de) * | 1936-10-29 | 1939-01-21 | I G Farbenindustrie Akt Ges | Verfahren zur Herstellung eines darm- und uterusanregenden Praeparates |
| US3069322A (en) * | 1958-05-28 | 1962-12-18 | Bergstrom Sune | Pge and pgf |
| JPS5829711A (ja) * | 1981-08-17 | 1983-02-22 | Koukandou:Kk | ジャコウ類似生薬 |
-
1984
- 1984-02-13 SE SE8400752A patent/SE454646B/sv unknown
-
1985
- 1985-01-29 IL IL74183A patent/IL74183A/xx unknown
- 1985-02-12 ES ES540308A patent/ES8607729A1/es not_active Expired
- 1985-02-12 WO PCT/SE1985/000070 patent/WO1985003441A1/en not_active Ceased
- 1985-02-12 AU AU39366/85A patent/AU586157B2/en not_active Ceased
- 1985-02-12 EP EP85901111A patent/EP0172873B1/de not_active Expired
- 1985-02-12 DE DE8585901111T patent/DE3570039D1/de not_active Expired
- 1985-02-12 CA CA000474058A patent/CA1240922A/en not_active Expired
- 1985-02-12 AT AT85901111T patent/ATE42897T1/de active
- 1985-02-12 JP JP85500792A patent/JPS61501394A/ja active Pending
- 1985-09-24 DK DK432085A patent/DK160536C/da not_active IP Right Cessation
- 1985-09-24 FI FI853664A patent/FI80593C/fi not_active IP Right Cessation
- 1985-10-11 NO NO85854049A patent/NO165944C/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI853664A0 (fi) | 1985-09-24 |
| IL74183A0 (en) | 1985-04-30 |
| NO165944B (no) | 1991-01-28 |
| DK432085D0 (da) | 1985-09-24 |
| AU3936685A (en) | 1985-08-27 |
| AU586157B2 (en) | 1989-07-06 |
| EP0172873B1 (de) | 1989-05-10 |
| IL74183A (en) | 1990-02-09 |
| ATE42897T1 (de) | 1989-05-15 |
| NO854049L (no) | 1985-10-11 |
| NO165944C (no) | 1991-05-08 |
| SE8400752D0 (sv) | 1984-02-13 |
| DK160536C (da) | 1991-09-09 |
| DK160536B (da) | 1991-03-25 |
| WO1985003441A1 (en) | 1985-08-15 |
| FI853664L (fi) | 1985-09-24 |
| FI80593B (fi) | 1990-03-30 |
| SE8400752L (sv) | 1985-08-14 |
| ES540308A0 (es) | 1986-06-01 |
| JPS61501394A (ja) | 1986-07-10 |
| EP0172873A1 (de) | 1986-03-05 |
| CA1240922A (en) | 1988-08-23 |
| DE3570039D1 (en) | 1989-06-15 |
| FI80593C (fi) | 1990-07-10 |
| DK432085A (da) | 1985-09-24 |
| ES8607729A1 (es) | 1986-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Foor | Ultrastructural aspects of oocyte development and shell formation in Ascaris lumbricoides | |
| Belt et al. | Cytoplasmic granules and relaxin levels in porcine corpora lutea | |
| New | Whole‐embryo culture and the study of mammalian embryos during organogenesis | |
| Wagner et al. | Immunological and biological evidence for a stanniocalcin-like hormone in human kidney. | |
| Ganz et al. | Vasoactive intestinal peptide: vasodilatation and cyclic AMP generation | |
| Stone et al. | Adipokinetic hormone | |
| Boulton et al. | Changes in content of mRNA encoding oxytocin in the pig uterus during the oestrous cycle, pregnancy, at parturition and in lactational anoestrus | |
| Jones et al. | The structure of the male genital system of the Port Jackson shark, Heterodontus portujacksoni, with particular reference to the genital ducts | |
| EP0107045A1 (de) | Verfahren zur Gewinnung von Relaxin aus Milch | |
| Campos‐Bedolla et al. | Effect of kauranes from Montanoa spp. on rat uterus | |
| Viscuso et al. | Role of male accessory glands in spermatodesm reorganization in Orthoptera Tettigonioidea | |
| SE454646B (sv) | Erektions- och fertilitetsbefremjande medel fran cowper's- och/eller bartholini's kortlar fran deggdjur inbegripet menniskan samt sett for framstellning derav | |
| Nissen | On lipid droplets in renal interstitial cells: III. A histological study on the number of droplets during hydration and dehydration | |
| Allegra et al. | Endocrine activity in a large hibernoma | |
| EP0512102A1 (de) | Aus säugetier schwangerschaftsspezifischem gewebe gereinigte, die zellvermehrung kontrollierende proteine | |
| Lai et al. | Pathogenesis of swine vesicular disease in pigs | |
| Krause et al. | Morphological observations on the metanephros in the postnatal opossum, Didelphis virginiana | |
| Russo et al. | Neuroendocrine cells in the vestibular glands of the genital tract of cows and pigs | |
| Björkman et al. | The ultrastructural organization and the alkaline phosphatase activity of the epithelial surface of the bovine fallopian tube | |
| Bunnett et al. | Catabolism of bombesin in the interstitial fluid of the rat stomach | |
| JPH07502755A (ja) | 胎盤タンパク質１４を使用する，再発性流産の治療法と繁殖補助技術の効能の改善法 | |
| Hall et al. | Hormonal dependence of cyclic patterns in hamster uterine fluid proteins | |
| Welch | Enchytraeidae (Oligochaeta) from the Rocky Mountain region | |
| WALLACE et al. | Hypothalamic immunoreactive neurotensin: changes induced by stress | |
| Palomares et al. | Chronic inflammatory and degenerative endometrial lesions in subfertile Criollo Limonero cattle; a B. taurus Latin-American breed threatened with extinction; A case-control study |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8400752-5 Format of ref document f/p: F |